These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 9360930)

  • 41. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TEL-JAK2 transgenic mice develop T-cell leukemia.
    Carron C; Cormier F; Janin A; Lacronique V; Giovannini M; Daniel MT; Bernard O; Ghysdael J
    Blood; 2000 Jun; 95(12):3891-9. PubMed ID: 10845925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins.
    Takemoto S; Mulloy JC; Cereseto A; Migone TS; Patel BK; Matsuoka M; Yamaguchi K; Takatsuki K; Kamihira S; White JD; Leonard WJ; Waldmann T; Franchini G
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13897-902. PubMed ID: 9391124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of the NF-kappaB pathway in the transforming properties of the TEL-Jak2 leukemogenic fusion protein.
    Santos SC; Monni R; Bouchaert I; Bernard O; Gisselbrecht S; Gouilleux F; Penard-Lacronique V
    FEBS Lett; 2001 May; 497(2-3):148-52. PubMed ID: 11377430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells.
    Demoulin JB; Uyttenhove C; Lejeune D; Mui A; Groner B; Renauld JC
    Cancer Res; 2000 Jul; 60(14):3971-7. PubMed ID: 10919676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity.
    Buijs A; van Rompaey L; Molijn AC; Davis JN; Vertegaal AC; Potter MD; Adams C; van Baal S; Zwarthoff EC; Roussel MF; Grosveld GC
    Mol Cell Biol; 2000 Dec; 20(24):9281-93. PubMed ID: 11094079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The tumor suppressor activity of SOCS-1.
    Rottapel R; Ilangumaran S; Neale C; La Rose J; Ho JM; Nguyen MH; Barber D; Dubreuil P; de Sepulveda P
    Oncogene; 2002 Jun; 21(28):4351-62. PubMed ID: 12080466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of a SRC-like tyrosine kinase gene, FRK, fused with ETV6 in a patient with acute myelogenous leukemia carrying a t(6;12)(q21;p13) translocation.
    Hosoya N; Qiao Y; Hangaishi A; Wang L; Nannya Y; Sanada M; Kurokawa M; Chiba S; Hirai H; Ogawa S
    Genes Chromosomes Cancer; 2005 Mar; 42(3):269-79. PubMed ID: 15611931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells.
    Nosaka T; Kawashima T; Misawa K; Ikuta K; Mui AL; Kitamura T
    EMBO J; 1999 Sep; 18(17):4754-65. PubMed ID: 10469654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
    Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
    Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C; Susini C; Melmed S
    J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein.
    Jousset C; Carron C; Boureux A; Quang CT; Oury C; Dusanter-Fourt I; Charon M; Levin J; Bernard O; Ghysdael J
    EMBO J; 1997 Jan; 16(1):69-82. PubMed ID: 9009269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
    Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
    Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haemopoietic transformation by the TEL/ABL oncogene.
    Hannemann JR; McManus DM; Kabarowski JH; Wiedemann LM
    Br J Haematol; 1998 Jul; 102(2):475-85. PubMed ID: 9695962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
    Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
    Le MN; Kohanski RA; Wang LH; Sadowski HB
    Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanism of transcriptional repression by TEL/RUNX1 fusion protein.
    Lee YJ; Kim JH; Bae S; Rho SK; Choe SY
    Mol Cells; 2004 Apr; 17(2):217-22. PubMed ID: 15179033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simultaneous activation of JAK1 and JAK2 confers IL-3 independent growth on Ba/F3 pro-B cells.
    Huang HM; Lin YL; Chen CH; Chang TW
    J Cell Biochem; 2005 Oct; 96(2):361-75. PubMed ID: 15988755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells.
    Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K
    Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
    Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.